MYUNGMOON Pharm co.,Ltd (KRX:017180)
1,650.00
-16.00 (-0.96%)
Feb 14, 2025, 9:00 AM KST
MYUNGMOON Pharm co.,Ltd Revenue
MYUNGMOON Pharm co.,Ltd had revenue of 46.98B KRW in the quarter ending September 30, 2024, with 8.74% growth. This brings the company's revenue in the last twelve months to 180.14B, up 8.07% year-over-year. In the year 2023, MYUNGMOON Pharm co.,Ltd had annual revenue of 169.57B with 11.46% growth.
Revenue (ttm)
180.14B
Revenue Growth
+8.07%
P/S Ratio
0.31
Revenue / Employee
638.80M
Employees
282
Market Cap
56.16B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 169.57B | 17.43B | 11.46% |
Dec 31, 2022 | 152.13B | 14.38B | 10.43% |
Dec 31, 2021 | 137.76B | 9.91B | 7.75% |
Dec 31, 2020 | 127.85B | -21.49B | -14.39% |
Dec 31, 2019 | 149.35B | 1.85B | 1.25% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,364.39B |
Celltrion | 2,876.25B |
Yuhan | 2,008.84B |
SK Biopharmaceuticals | 511.33B |
SK bioscience | 201.30B |
Hanmi Pharm. | 1,495.50B |
Hanall Biopharma | 134.24B |
Hanmi Science | 1,283.65B |